Medanta Q4 PAT falls 20%, revenue rises 15% on strong patient volume

Global Health reports Q4FY25 PAT drop to ₹101.4 crore on one-time expense; revenue up 15% to ₹931.2 crore; expansion plans include 550-bed Noida facility by FY26

Medanta Hospital
Medanta’s international patient revenue rose 17 per cent Y-o-Y to ₹55.7 crore, contributing 6 per cent to total revenue in the March quarter.
Sanket Koul New Delhi
2 min read Last Updated : May 16 2025 | 7:30 PM IST
Global Health Limited (GHL), which operates Medanta Hospitals, reported a 20.4 per cent year-on-year (Y-o-Y) drop in consolidated profit after tax (PAT) for the March quarter (Q4FY25) to ₹101.4 crore, down from ₹127.3 crore in the same period last year.
 
The company’s revenue from operations rose 15.2 per cent Y-o-Y to ₹931.2 crore in Q4FY25, compared to ₹808.6 crore in Q4FY24.
 
GHL stated that the decline in PAT was due to a non-recurring exceptional expense of ₹49.9 crore related to the merger of MHPL (Manipal’s Lucknow entity) with GHL.
 
Medanta also announced that it is on track to commence operations at its upcoming 550-bed hospital in Noida by the second quarter of FY26.
 
Commenting on the expansion, Pankaj Sahni, group chief executive officer (CEO) and director, said the move is part of a broader plan to add 1,000 beds over the next two years, enhancing Medanta’s capacity to serve growing patient demand.
 
On a consolidated basis, the company’s earnings before interest, tax, depreciation, and amortisation (Ebitda) rose 19.8 per cent to ₹247.6 crore in Q4FY25. Ebitda margins stood at 26 per cent, up from 24.8 per cent in Q3FY24.
 
For the December quarter, Global Health reported a 12.3 per cent Y-o-Y growth in average occupied bed days, with an occupancy rate of 61.3 per cent driven by increased bed capacity.
 
The company reported a marginal rise in average revenue per occupied bed (ARPOB) per day to ₹63,629 in Q4FY25, up 0.9 per cent from ₹63,063 in the same period last year.
 
Medanta’s international patient revenue rose 17 per cent Y-o-Y to ₹55.7 crore, contributing 6 per cent to total revenue in the March quarter.
 
On Friday, Global Health Limited’s stock fell 3.26 per cent, ending the day’s trade at ₹1,202.65 apiece on the Bombay Stock Exchange (BSE).
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :MedantaQ4 ResultsMedanta Hospitals

First Published: May 16 2025 | 7:30 PM IST

Next Story